These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3602322)

  • 1. An investigation of the coexistence of abnormal involuntary movements, parkinsonism, and akathisia in chronic psychiatric inpatients.
    Kucharski LT; Wagner RL; Friedman JH
    Psychopharmacol Bull; 1987; 23(1):215-7. PubMed ID: 3602322
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexisting tardive dyskinesia and parkinsonism: a case report.
    De Fraites EG; Davis KL; Berger PA
    Biol Psychiatry; 1977 Apr; 12(2):267-72. PubMed ID: 857938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coexistence of parkinsonism-like symptoms and tardive dyskinesia.
    Richardson MA; Craig TJ
    Am J Psychiatry; 1982 Mar; 139(3):341-3. PubMed ID: 6120656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akathisia: a distressing complication of neuroleptic treatment.
    Szabadi E
    Compr Ther; 1987 Sep; 13(9):3-6. PubMed ID: 2889560
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetry of abnormal involuntary movements: a prevalence study.
    Myslobodsky MS; Holden T; Sandler R
    Biol Psychiatry; 1984 Apr; 19(4):623-8. PubMed ID: 6145450
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of tolerance to the therapeutic effect of amantadine on akathisia.
    Zubenko GS; Barreira P; Lipinski JF
    J Clin Psychopharmacol; 1984 Aug; 4(4):218-20. PubMed ID: 6470196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
    Shoulson I
    Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
    Fahn S
    Adv Neurol; 1983; 37():267-76. PubMed ID: 6858776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.
    Stahl SM; Yesavage JA; Berger PA
    J Clin Psychiatry; 1982 Nov; 43(11):445-6. PubMed ID: 7174619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC; Atbaşoğlu EC; Balaban H
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is it? Case 3, 1991: moaning in a man with parkinsonian signs.
    Micheli F; Fernandez Pardal M; Giannaula R; Fahn S
    Mov Disord; 1991; 6(4):376-8. PubMed ID: 1758460
    [No Abstract]   [Full Text] [Related]  

  • 15. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?
    Crow TJ; Cross AJ; Johnstone EC; Owen F; Owens DG; Waddington JL
    J Clin Psychopharmacol; 1982 Oct; 2(5):336-40. PubMed ID: 7130435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical pathology and pharmacology of brain dopamine and acetylcholine: rational basis for the current drug treatment of Parkinsonism.
    Hornykiewicz O
    Contemp Neurol Ser; 1971; 8():33-65. PubMed ID: 5162181
    [No Abstract]   [Full Text] [Related]  

  • 18. Propranolol-induced tardive dyskinesia in a patient with akathisia.
    Sandyk R
    Ann Neurol; 1985 Sep; 18(3):370. PubMed ID: 4051467
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.
    Grimes JD
    Can Med Assoc J; 1982 Mar; 126(5):468. PubMed ID: 6121618
    [No Abstract]   [Full Text] [Related]  

  • 20. Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons.
    Fulceri F; Biagioni F; Ferrucci M; Lazzeri G; Bartalucci A; Galli V; Ruggieri S; Paparelli A; Fornai F
    Brain Res; 2007 Mar; 1135(1):219-29. PubMed ID: 17222394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.